OTCMKTS:GNBT - Generex Biotechnology Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$8.25 -0.95 (-10.33 %)
(As of 10/17/2018 04:00 PM ET)
Previous Close$9.20
Today's Range$8.25 - $9.95
52-Week Range$1.76 - $11.65
Volume6,120 shs
Average Volume2,868 shs
Market Capitalization$2.45 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.33
Generex Biotechnology Corporation, through its subsidiary, Hema Diagnostic Systems, LLC, focuses on the development, manufacture, and distribution of in-vitro medical diagnostics for infectious diseases in Canada and the United States. The company offers Rapid Diagnostic Tests for human immunodeficiency virus?½ w/p24Ab, tuberculosis-XT, malaria, hepatitis, syphilis, typhoid, dengue, and other infectious diseases. Generex Biotechnology Corporation was founded in 1983 and is based in Miramar, Florida.

Receive GNBT News and Ratings via Email

Sign-up to receive the latest news and ratings for GNBT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:GNBT
CUSIPN/A
Phone416-364-2551

Debt

Debt-to-Equity RatioN/A
Current Ratio0.07
Quick Ratio0.07

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash Flow$63.4615 per share
Price / Cash0.13
Book Value($74.78) per share
Price / Book-0.11

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-70,010,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-166.13%

Miscellaneous

Employees12
Outstanding Shares1,070,000
Market Cap$2.45 million

Generex Biotechnology (OTCMKTS:GNBT) Frequently Asked Questions

What is Generex Biotechnology's stock symbol?

Generex Biotechnology trades on the OTCMKTS under the ticker symbol "GNBT."

When is Generex Biotechnology's next earnings date?

Generex Biotechnology is scheduled to release their next quarterly earnings announcement on Thursday, October 25th 2018. View Earnings Estimates for Generex Biotechnology.

Who are some of Generex Biotechnology's key competitors?

Who are Generex Biotechnology's key executives?

Generex Biotechnology's management team includes the folowing people:
  • Mr. Joseph Moscato, Chief Exec. Officer, Pres and Director (Age 54)
  • Mr. Mark Corrao, CFO & Treasurer (Age 59)
  • Mr. Andrew Ro, Chief Investment Officer, Sr. VP of Investments & Director (Age 47)
  • Mr. Mark A. Fletcher Esq., Exec. VP, Gen. Counsel & Sec. (Age 53)
  • Mr. Richard D. Purcell, Sr. VP of Research & Drug Devel. (Age 57)

How do I buy shares of Generex Biotechnology?

Shares of GNBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Generex Biotechnology's stock price today?

One share of GNBT stock can currently be purchased for approximately $8.25.

How big of a company is Generex Biotechnology?

Generex Biotechnology has a market capitalization of $2.45 million. Generex Biotechnology employs 12 workers across the globe.

What is Generex Biotechnology's official website?

The official website for Generex Biotechnology is http://www.generex.com.

How can I contact Generex Biotechnology?

Generex Biotechnology's mailing address is 10102 USA TODAY WAY, MIRAMAR FL, 33025. The company can be reached via phone at 416-364-2551 or via email at [email protected]


MarketBeat Community Rating for Generex Biotechnology (OTCMKTS GNBT)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  96
MarketBeat's community ratings are surveys of what our community members think about Generex Biotechnology and other stocks. Vote "Outperform" if you believe GNBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel